UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Treatment patterns for patients initiating novel acute migraine specific medications (nAMSMs) in the context of monoclonal antibodies (mAbs) targeting the calcitonin gene-related peptide (CGRP) pathway

Journal of headache and pain, 2023-11, Vol.24 (1), p.153-153, Article 153

2023

Volltextzugriff (PDF)

The current treatment landscape in adult atopic dermatitis in the United States: results from a cross-sectional real-world study

The Journal of dermatological treatment, 2022-04, Vol.33 (3), p.1707-1717

2022

Volltextzugriff (PDF)

Nephrotoxicity and other adverse events among inpatients receiving liposomal amphotericin B or amphotericin B lipid complex

Diagnostic microbiology and infectious disease, 2013-07, Vol.76 (3), p.361-367

2013

Volltextzugriff (PDF)

Economic burden and risk factors of migraine disease progression in the US: a retrospective analysis of a commercial payer database

Journal of medical economics, 2020-11, Vol.23 (11), p.1356-1364

2020

Volltextzugriff (PDF)

Geographic variations in lipid-lowering therapy utilization, LDL-C levels, and proportion retrospectively meeting the ACC/AHA very high-risk criteria in a real-world population of patients with major atherosclerotic cardiovascular disease events in the United States

American journal of preventive cardiology, 2021-06, Vol.6, p.100177-100177, Article 100177

2021

Volltextzugriff (PDF)

Medication adherence, hospitalization, and healthcare resource utilization and costs in patients with pulmonary arterial hypertension treated with endothelin receptor antagonists or phosphodiesterase type-5 inhibitors

Pulmonary circulation, 2020-01, Vol.10 (1), p.1-11

2020

Volltextzugriff (PDF)

Orphan Drug Expenditures In The United States: A Historical And Prospective Analysis, 2007-18

Health Affairs, 2016-09, Vol.35 (9), p.1588-1594

2016

Volltextzugriff (PDF)

Patient Carrying Time, Confidence, and Training with Epinephrine Autoinjectors: The RACE Survey

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2019-09, Vol.7 (7), p.2252-2261

2019

Volltextzugriff (PDF)

Erenumab patient characteristics, medication adherence, and treatment patterns in the United States

Headache, 2021-04, Vol.61 (4), p.590-602

2021

Volltextzugriff (PDF)

Outcome evaluation of a subcutaneous immunoglobulin clinical management program

Journal of Research in Pharmacy Practice, 2019-04, Vol.8 (2), p.52-63

2019

Volltextzugriff (PDF)

Adherence and Persistence Patterns in Medication Use Among Men With Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia

American journal of men's health, 2017-01, Vol.11 (1), p.164-169

2017

Volltextzugriff (PDF)

Medical management patterns in a US commercial claims database following a nontraumatic fracture in postmenopausal women

Archives of osteoporosis, 2022-12, Vol.17 (1), p.92-92, Article 92

2022

Volltextzugriff (PDF)

Previously unrecognized risk factors for severe hypoglycaemia requiring emergency medical care in insulin‐treated type 2 diabetes: Results from a real‐world nested case‐control study

Diabetes, obesity & metabolism, 2022-07, Vol.24 (7), p.1235-1244

2022

Volltextzugriff (PDF)

Geographic variation in disease burden among patients with severe persistent asthma in the United States

Annals of allergy, asthma, & immunology, 2024-05, Vol.132 (5), p.602-609.e4

2024

Volltextzugriff (PDF)

Inadequate response and treatment patterns in adults diagnosed with atopic dermatitis and treated with topical therapy

The Journal of dermatological treatment, 2022-07, Vol.33 (5), p.2510-2517

2022

Volltextzugriff (PDF)

Impact of Oxycodone HCl Extended-release Formulary Restrictions on Extended-release Opioid Market Share, Healthcare Resource Utilization and Costs in Commercial and Medicare Plans

Journal of health economics and outcomes research (Online), 2017-07, Vol.5 (1), p.75-88

2017

Volltextzugriff (PDF)

US health care utilization and costs in adult patients with atopic dermatitis by disease severity

Journal of managed care & specialty pharmacy, 2022-01, Vol.28 (1), p.69-77

2022

Volltextzugriff (PDF)

Economic burden of skeletal-related events in patients with multiple myeloma: analysis of US commercial claims database

Journal of medical economics, 2018-06, Vol.21 (6), p.622-628

2018

Volltextzugriff (PDF)

Pharmaceutical expenditure on drugs for rare diseases in Canada: a historical (2007-13) and prospective (2014-18) MIDAS sales data analysis

Orphanet journal of rare diseases, 2016-05, Vol.11 (1), p.68-68, Article 68

2016

Volltextzugriff (PDF)

Two-year adherence and costs for biologic therapy for rheumatoid arthritis

The American journal of managed care, 2018-07, Vol.24 (8 Spec No.), p.SP315-SP321

2018

Volltextzugriff (PDF)

Economic and Clinical Burden of Acute Myeloid Leukemia Episodes of Care in the United States: A Retrospective Analysis of a Commercial Payer Database

Journal of managed care & specialty pharmacy, 2020-07, Vol.26 (7), p.849-859

2020

Volltextzugriff (PDF)

Treatment patterns and patient characteristics among early initiators of PCSK9 inhibitors

Vascular health and risk management, 2018-01, Vol.14, p.409-418

2018

Volltextzugriff (PDF)

Using Real World Evidence to Describe Pulmonary Arterial Hypertension Treatment Patterns, Healthcare Resource Utilization, and Costs Associated with PDE-5 Inhibitor Monotherapy

Journal of health economics and outcomes research (Online), 2018, Vol.5 (2), p.206-219

2018

Volltextzugriff (PDF)

Patient characteristics and acute cardiovascular event rates among patients with very high‐risk and non‐very high‐risk atherosclerotic cardiovascular disease

Clinical cardiology (Mahwah, N.J.), 2021-10, Vol.44 (10), p.1457-1466

2021

Volltextzugriff (PDF)

Identifying disability level in multiple sclerosis patients in a U.S.-based health plan claims database

Journal of medical economics, 2021-01, Vol.24 (1), p.46-53

2021

Volltextzugriff (PDF)

1 – 25 von 71

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(67)
Mit Volltextzugriff
(59)

Publikationsform

Artikel
(71)

Sprache

Englisch
(71)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Treatment patterns for patients initiating novel acute migraine specific medications (nAMSMs) in the context of monoclonal antibodies (mAbs) targeting the calcitonin gene-related peptide (CGRP) pathway

The current treatment landscape in adult atopic dermatitis in the United States: results from a cross-sectional real-world study

Nephrotoxicity and other adverse events among inpatients receiving liposomal amphotericin B or amphotericin B lipid complex

Economic burden and risk factors of migraine disease progression in the US: a retrospective analysis of a commercial payer database

Geographic variations in lipid-lowering therapy utilization, LDL-C levels, and proportion retrospectively meeting the ACC/AHA very high-risk criteria in a real-world population of patients with major atherosclerotic cardiovascular disease events in the United States

Medication adherence, hospitalization, and healthcare resource utilization and costs in patients with pulmonary arterial hypertension treated with endothelin receptor antagonists or phosphodiesterase type-5 inhibitors

Orphan Drug Expenditures In The United States: A Historical And Prospective Analysis, 2007-18

Patient Carrying Time, Confidence, and Training with Epinephrine Autoinjectors: The RACE Survey

Erenumab patient characteristics, medication adherence, and treatment patterns in the United States

Outcome evaluation of a subcutaneous immunoglobulin clinical management program

Adherence and Persistence Patterns in Medication Use Among Men With Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia

Medical management patterns in a US commercial claims database following a nontraumatic fracture in postmenopausal women

Previously unrecognized risk factors for severe hypoglycaemia requiring emergency medical care in insulin‐treated type 2 diabetes: Results from a real‐world nested case‐control study

Geographic variation in disease burden among patients with severe persistent asthma in the United States

Inadequate response and treatment patterns in adults diagnosed with atopic dermatitis and treated with topical therapy

Impact of Oxycodone HCl Extended-release Formulary Restrictions on Extended-release Opioid Market Share, Healthcare Resource Utilization and Costs in Commercial and Medicare Plans

US health care utilization and costs in adult patients with atopic dermatitis by disease severity

Economic burden of skeletal-related events in patients with multiple myeloma: analysis of US commercial claims database

Pharmaceutical expenditure on drugs for rare diseases in Canada: a historical (2007-13) and prospective (2014-18) MIDAS sales data analysis

Two-year adherence and costs for biologic therapy for rheumatoid arthritis

Economic and Clinical Burden of Acute Myeloid Leukemia Episodes of Care in the United States: A Retrospective Analysis of a Commercial Payer Database

Treatment patterns and patient characteristics among early initiators of PCSK9 inhibitors

Using Real World Evidence to Describe Pulmonary Arterial Hypertension Treatment Patterns, Healthcare Resource Utilization, and Costs Associated with PDE-5 Inhibitor Monotherapy

Patient characteristics and acute cardiovascular event rates among patients with very high‐risk and non‐very high‐risk atherosclerotic cardiovascular disease

Identifying disability level in multiple sclerosis patients in a U.S.-based health plan claims database

Suchergebnisse filtern